ALB and COVID-19: The following laboratory studies showed significant improvement after resolution of COVID-19: aspartate aminotransferase [median (IQR) peak–>recovery, 58 (65)–>27 (21) IU/ml; p<0.0001), ALT [39 (58)–>26 (24) IU/ml; p<0.0001], bilirubin [0.6 (0.4)–>0.5 (0.4) mg/dl; p<0.0001), albumin [3.0 (1.1)–>3.9 (1.0) g/dl; p<0.0001], international normalized ratio [1.2 (0.3)–>1.1 (0.3); p<0.0001], and creatinine [1.1 (1.0)–>0.9 (0.5) mg/dl; p=0.0002].